Affordable Access

Publisher Website

Immune effects of α-interferon in chronic liver disease

Elsevier B.V.
Publication Date
DOI: 10.1016/s0168-8278(86)80133-7
  • Session G: Possible Modes Of Action Of The Interferons In Chronic Hepatitis B Virus Infection
  • Medicine


Summary The effect of prolonged α-interferon therapy on immune function was studied in patients with chronic type B hepatitis. These patients with chronic type B hepatitis have been shown to have a defect in their in vitro response to human recombinant α-interferon. This defect consists of a failure to augment pokeweed mitogen-stimulated immunoglobulin production at low concentrations of interferon and an increased susceptibility to the suppressive effects of interferon. After 2 weeks therapy with interferon, immunoglobulin production was further suppressed. However, after 4 months of therapy with interferon, pokeweed mitogen-stimulated immunoglobulin production partially returned towards the pretreatment values. Antibody to hepatitis B core antigen was less affected by interferon therapy. This altered response to interferon was not specific as it was seen in some patients with other forms of liver disease. The suppression of B cell differentiation appears to be separate from its antiviral and anti-proliferative effects.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Differential antiviral effects of pegylated interf...

on Clinical drug investigation December 2014

Effects of interferon therapy on fibrosis serum ma...

on European journal of gastroente... February 1998

Immune complexes in acute and chronic liver diseas...

on Clinical & Experimental Immuno... February 1978
More articles like this..